| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |